Buprenorphine Cost Effectiveness

More documents

Recommendations

Info

Cost-effectiveness Ratio Additional Resources Used ($) Additional Health Benefits Gained (QALYs) 8
Cost-effectiveness vs cost-benefit? • Cost-benefit analysis (CBA) allows consideration of benefits and costs outside the health care system – CBAs have shown methadone maintenance to be costsaving considering savings in crime costs, welfare payments, and health care costs and/or increases in earnings 1 • Issues: – Lack of data requires extrapolation from studies of methadone treatment and heroin use; may not be relevant to prescription opioid dependent patients – CBA is not commonly accepted for evaluating medical treatments; cannot compare results to other pharmaceutical interventions 1 Simoens et. al, Drug Alcohol Dep, 2006 9
Page 1 and 2: Buprenorphine Cost Effectiveness Br
Page 3 and 4: Buprenorphine Cost • Cost has bee
Page 5 and 6: Cost-effectiveness ≠ Cost saving
Page 7: Questions Policy Makers Should Ask
Page 11 and 12: Published Cost-Effectiveness Studie
Page 13 and 14: Enter In Treatment Off Drugs In Tre
Page 15 and 16: Cohort Retention In Treatment By Mo
Page 17 and 18: Limitations • Cohort treated at a
Page 19: • David Fiellin, MD • Jared Lef

Buprenorphine Cost Effectiveness

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?